Therapeutic Outcome of Alemtuzumab in Korean Patients with Multiple Sclerosis: 2-Year Follow-Up

BACKGROUND AND PURPOSE: Alemtuzumab has shown high efficacy in clinical trials that primarily involved Western multiple sclerosis (MS) patients. To evaluate the therapeutic outcome of alemtuzumab in Korean patients with MS. METHODS: This study enrolled 23 consecutive patients who were treated with a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Neurol
Autors principals: Hyun, Jae-Won, Shin, Hyun-June, Jang, Hyunmin, Park, Na Young, Kim, Su-Hyun, Kim, Ho Jin
Format: Artigo
Idioma:Inglês
Publicat: Korean Neurological Association 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6620458/
https://ncbi.nlm.nih.gov/pubmed/31286704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3988/jcn.2019.15.3.328
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars